Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |